A RNA polymerase for record low dsRNA levels
Contaminating dsRNA represents a serious limitation in downstream applications, as it impairs mRNA expression and can induce an undesired immune response. This is typically mitigated using downstream purification strategies, alteration of the IVT conditions, and the use of bacteriophage RNA polymerases homologs of T7 RNAP or its mutants. However, these strategies present problems of costly scaling, incomplete reduction of dsRNA contamination, or/and low yield of the target RNA.
Our patented T7RNAP produces both low levels of dsRNA (as low as 0.01% w/w), while at the same time maintaining the RNA yield.